Founded in 1992 by president and CEO, Jinsoo Kim, Image Solutions, Inc. (ISI) has played a pioneering role in the worldwide movement toward acceptance and standardization of PDF-based electronic submissions. Today, ISI is a recognized leader in the area of electronic submissions of New Drug Applications (NDA's).

By designing, developing, implementing, and supporting advanced imaging technologies, ISI has assisted many of the world's foremost pharmaceutical companies in reducing the time and cost associated with eNDA development, compilation, submission, and review. Furthermore, ISI has applied our expertise to expand our offer to Legal, Insurance, Financial Services, Publishing, and other regulated industries.

With our staff of highly trained professionals, ISI offers a wide array of innovative and specialized products and services. ISI and our associates have a broad range of expertise in workflow design, project management, document management, medical writing, software design, development and training, as well as systems and software integration.

We are uniquely positioned to help our customers with our ability to provide the appropriate mix of software technology, professional services, and/or training to ensure our client's success.

Accolades
ISI's innovative work is included in the Smithsonian Institution's "Innovation in Science Collection" as a pioneer in the movement toward acceptance and standardization of Electronic Submissions to the FDA.

Integrity, Satisfaction, and Innovation have propelled ISI to Deloitte & Touche's prestigious "Technology Fast 50 " program in New Jersey and "Technology Fast 500" program in the U.S. four years in a row.

Commitment
ISI's commitment to community service is put into practice. We contribute 10% of our net profits to charitable causes, each year.